News & Updates

Show Multimedia Only
Fewer CV events after COVID-19 vaccine-related myocarditis
Fewer CV events after COVID-19 vaccine-related myocarditis
13 Sep 2024 byElvira Manzano

In a nationwide French cohort study, myocarditis attributed to COVID-19 mRNA vaccination causes fewer cardiovascular (CV) events at 18 months of follow-up than that attributed to SARS-CoV-2 infection or myocarditis of conventional aetiologies.

Fewer CV events after COVID-19 vaccine-related myocarditis
13 Sep 2024
LNG-IUS use ups risk of depression
LNG-IUS use ups risk of depression
11 Sep 2024 byStephen Padilla

Use of a levonorgestrel-releasing intrauterine system (LNG-IUS) appears to increase the risk of incident depression, defined as initiation of an antidepressant or receipt of a depression diagnosis, in a dose-dependent manner, suggests a study.

LNG-IUS use ups risk of depression
11 Sep 2024
Tenecteplase at 4.5–24 hours without thrombectomy feasible for ischaemic stroke
Tenecteplase at 4.5–24 hours without thrombectomy feasible for ischaemic stroke
11 Sep 2024 byAudrey Abella

The use of tenecteplase in the extended time window of 4.5–24 hours improves functional outcomes in patients with ischaemic stroke when endovascular thrombectomy (EVT) is not immediately available, findings from the phase III TRACE-III* trial suggest.

Tenecteplase at 4.5–24 hours without thrombectomy feasible for ischaemic stroke
11 Sep 2024